eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
3/2013
vol. 17
 
Share:
Share:
abstract:
Original paper

Expression of β-catenin and AXIN2 in ameloblastomas

Zhenhui Wei
,
Ming Zhong
,
Yan Guo
,
Yan Wang
,
Meisi Ren
,
Zhaoyuan Wang

Wspolczesna Onkol 2013; 17 (3): 250–256
Online publish date: 2013/06/28
View full text Get citation
 
PlumX metrics:
Aim of the study: To investigate the ex­pression status and association of β-ca­tenin and AXIN2 in ameloblastoma.

Material and methods: 30 ameloblastoma specimens and 10 normal oral mucosa tissues were enrolled in the study. The protein and RNA levels of

β-ca­tenin and AXIN2 were detected by immunohistochemistry staining, Western blot, and real-time PCR analysis. The relationship between β-catenin and AXIN2 protein and clinico-pathological parameters and prognosis was subsequently determined.

Results: The results show that β-catenin mRNA expression was 1.24-fold higher in ameloblastomas than that in normal mucosa tissues, but AXIN2 mRNA expression was 0.47-fold lower in ameloblastomas than that in normal mucosa tissues (p < 0.05). The Western blot results show that β-catenin and AXIN2 protein in ameloblastomas had a significantly higher level than normal mucosa tissues

(p < 0.05). Immunohistochemical staining of β-catenin and AXIN2 protein in ame­loblastoma was expressed at a higher level than normal oral mucosa (p < 0.05).

Conclusions: AXIN2 and β-catenin play an important role in the tumorigenesis and progression of ameloblastoma.
keywords:

ameloblastoma, β-catenin, AXIN2, Wnt pathway

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.